Dosage of Augmentin for a 2-Year-Old with Otitis Media Weighing 35 kg
For a 2-year-old child with otitis media weighing 35 kg, the recommended dosage of Augmentin (amoxicillin/clavulanate) is 80-90 mg/kg/day of the amoxicillin component, divided into two doses, which equals approximately 1400-1575 mg twice daily. 1
Dosage Calculation
For a 35 kg child, the appropriate dosage calculation is:
For children weighing ≥40 kg, adult dosing would apply, but at 35 kg, pediatric weight-based dosing is still appropriate 2
Formulation Selection
- The appropriate formulation would be the high-dose amoxicillin/clavulanate suspension (typically 600 mg/5 mL or 400 mg/5 mL) 1, 2
- The 14:1 ratio of amoxicillin to clavulanate is preferred to minimize gastrointestinal side effects 1
Treatment Duration
- The recommended duration of therapy for acute otitis media is 10 days 2, 3
- Treatment should be administered at the start of a meal to enhance absorption of clavulanate and minimize gastrointestinal intolerance 2
Considerations for Treatment Selection
Amoxicillin/clavulanate is indicated in the following scenarios:
For children with penicillin allergy:
Monitoring Response to Treatment
- The child should begin to show clinical improvement within 24-48 hours of starting therapy 1
- If no improvement is seen within 48-72 hours, reassessment is necessary to:
- Confirm the diagnosis of AOM
- Consider changing the antibiotic 1
Common Pitfalls to Avoid
- Using standard-dose amoxicillin/clavulanate instead of high-dose formulation may be inadequate for resistant organisms 1, 3
- Twice-daily dosing is preferred over three-times-daily dosing as it:
- Failure to administer with food increases the risk of gastrointestinal side effects 2
Additional Considerations
- Pain management should be addressed regardless of antibiotic use 1
- For children with vomiting or inability to tolerate oral medication, a single 50 mg/kg dose of ceftriaxone (IV or IM) can be given initially 1
- The twice-daily regimen of amoxicillin/clavulanate has shown equivalent efficacy to three-times-daily dosing with better compliance 4, 5